Gossamer Bio, Inc.

NASDAQ:GOSS

1.05 (USD) • At close January 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 9.4895.84206.784000000000000000000000000000
Cost of Revenue 00.9920.9861.0061.1011.1511.141.1231.111.0991.0971.2821.3141.2971.2740000000000000000
Gross Profit 9.4894.85-0.9865.778-1.101-1.151-1.14-1.123-1.11-1.099-1.097-1.282-1.314-1.297-1.2740000000000000000
Gross Profit Ratio 10.9900.852000000000000000000000000000
Reseach & Development Expenses 34.89734.83632.39229.67831.236.30937.79541.50844.50942.5842.32240.93243.1944.31841.82738.9141.84638.68441.41442.59640.14835.67624.98325.87218.8577.932.6240.6750.2120.0020.002
General & Administrative Expenses 8.5028.6699.5679.0579.299.97610.13212.83411.49711.27712.00110.71412.45911.26311.34615.87711.44811.65510.74811.5919.8389.6738.03413.93522.9064.6062.6040.1570.0760.0150.015
Selling & Marketing Expenses 0-0.7420-0.714000000000000000000000000000
SG&A 8.5027.9279.5678.3439.299.97610.13212.83411.49711.27712.00110.71412.45911.26311.34615.87711.44811.65510.74811.5919.8389.6738.03413.93522.9064.6062.6040.1570.0760.0150.015
Other Expenses 02.7472.8163.8083.426.5381.691.456-0.3320.587-0.1990.0780.1150.4570.149-0.13-4.243-1.5310.8931.0891.4861.8510.3760.3190.6220.300000
Operating Expenses 43.39942.76341.95938.02140.4946.28547.92754.34256.00653.85754.32351.64655.64955.58153.17354.78753.29450.33952.16254.18749.98645.34933.01739.80741.76312.5365.2280.8320.2880.0170.017
Operating Income -33.91952.087-41.959-39.027-40.49-46.3-47.942-54.357-56.021-53.872-54.343-51.661-55.664-55.596-53.203-60.087-53.569-65.339-54.967-55.787-49.986-46.349-34.017-39.807-50.024-33.036-26.126-6.332-0.288-0.017-0.017
Operating Income Ratio -3.5780.5430-5.753000000000000000000000000000
Total Other Income Expenses Net 1.9841.580.0310.8790.4823.804-1.223-1.407-3.342-2.594-3.442-4.623-4.583-4.236-4.438-4.517-4.243-1.5310.8931.091.4861.8511.4061.0130.6220.30.089-0.118000
Income Before Tax -31.93553.667-41.928-48.148-40.008-42.496-49.165-55.764-59.363-56.466-57.785-56.284-60.247-59.832-57.641-64.604-57.812-66.87-54.074-54.698-48.5-44.498-32.611-38.794-49.402-32.736-26.037-6.45-0.288-0.017-0.017
Income Before Tax Ratio -3.3690.560-7.097000000000000000000000000000
Income Tax Expense -1.1324.435-0.986-21.4536.7639.9674.7231.4223.3422.5943.442-19.445.0045.2914.9293.414-0.902152.805-0.86400.7950.3950.3238.26120.500000
Net Income -30.80349.232-41.928-48.148-40.008-42.496-53.888-57.186-62.705-59.06-61.227-56.284-60.247-59.832-57.641-64.604-57.812-66.87-54.074-54.698-48.5-44.498-32.611-38.794-49.402-32.736-26.037-6.45-0.288-0.017-0.017
Net Income Ratio -3.2490.5140-7.097000000000000000000000000000
EPS -0.140.22-0.19-0.21-0.21-0.45-0.57-0.61-0.69-0.77-0.81-0.74-0.8-0.8-0.78-0.88-0.8-1-0.87-0.89-0.8-0.74-0.9-1.56-1.99-1.32-1.05-0.26-0.031-0.002-0.002
EPS Diluted -0.140.21-0.19-0.21-0.21-0.45-0.57-0.61-0.69-0.77-0.81-0.74-0.8-0.8-0.78-0.88-0.8-1-0.87-0.89-0.8-0.74-0.9-1.56-1.99-1.32-1.05-0.26-0.031-0.002-0.002
EBITDA -28.10353.079-37.813-43.903-35.564-37.916-44.525-51.184-54.778-51.886-53.221-50.065-54.044-53.701-51.587-54.551-51.92-65.339-53.179-52.234-49.735-45.144-32.848-38.656-41.638-12.504-26.031-6.332000
EBITDA Ratio -2.9640.5540-5.605000000000000000000000000000